Washington, July 20 /PRNewswire-USNewswire/ — BIO
Ventures for Global Health (BVGH) announced today that it is
expanding to the West Coast with the opening of a new San Francisco headquarters office. The
expansion provides BVGH the opportunity to work even more closely
with the world class biotech and investor communities on both
coasts.
“We are very excited about our expansion and new location in the
Bay area, one of the premier biotech centers,” says Don Joseph, JD, Chief Operating Officer of
BVGH. “By establishing a West Coast location in addition to
our ongoing presence in Washington,
D.C., BVGH will be better able to connect with biotech
companies and investors, regardless of their location, as we seek
to expand companies’ involvement in addressing neglected diseases
of the developing world.”
BVGH also announced the appointment of two new senior staff.
Jacqueline Papkoff, PhD, was appointed Vice President of
Global Health Connect. Global Health Connect is a new network
created to link biopharmaceutical companies with product
development partnerships, academics, NGOs, developing country
researchers, and other experts involved in product research and
development for neglected diseases. Papkoff has worked for more
than 20 years in the biotech and pharmaceutical industry and has
extensive scientific leadership, management, and business
experience, including senior positions at diaDexus, Megabios,
SUGEN, and Hoechst. Before joining BVGH, she served as a
biotherapeutics R&D consultant as well as Chief Scientific
Officer of CFD Therapeutics, a preclinical cancer therapeutic
antibody company.
Nadine Weich, PhD, was appointed
Senior Director
‘/>”/>
